Junichi Nishimura

Osaka, 5418567, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 259 publications

Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.

Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.

Journal: International journal of clinical oncology

Published: April 12, 2026

Zolbetuximab-induced gastric mucosal injury and hypoalbuminemia: a mechanism-informed clinical analysis.

Zolbetuximab-induced gastric mucosal injury and hypoalbuminemia: a mechanism-informed clinical analysis.

Journal: Cancer chemotherapy and pharmacology

Published: February 14, 2026

Immunotherapy-Facilitated Conversion Surgery for Biliary Tract Cancer: A Case Series of Long-Term Survivors Following Durvalumab Combined With Gemcitabine and Cisplatin.

Immunotherapy-Facilitated Conversion Surgery for Biliary Tract Cancer: A Case Series of Long-Term Survivors Following Durvalumab Combined With Gemcitabine and Cisplatin.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: February 04, 2026

Effect of a preoperative coating agent on postoperative skin tears in pancreatectomy.

Effect of a preoperative coating agent on postoperative skin tears in pancreatectomy.

Journal: Surgery

Published: August 05, 2025

Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysis.

Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysis.

Journal: Surgery today

Published: April 21, 2025

Short- and long-term outcomes of robotic versus conventional laparoscopic surgery for middle or lower rectal cancer: a propensity score-matched analysis.

Short- and long-term outcomes of robotic versus conventional laparoscopic surgery for middle or lower rectal cancer: a propensity score-matched analysis.

Journal: International journal of colorectal disease

Published: April 05, 2025

Clinical and prognostic characteristics of metastatic colorectal cancer with minor RAS mutations.

Clinical and prognostic characteristics of metastatic colorectal cancer with minor RAS mutations.

Journal: Oncology letters

Published: March 17, 2025

Precision Spectral Measurements of Chromium and Titanium from 10 to 250 GeV/n and Sub-Iron to Iron Ratio with the Calorimetric Electron Telescope on the International Space Station.

Precision Spectral Measurements of Chromium and Titanium from 10 to 250 GeV/n and Sub-Iron to Iron Ratio with the Calorimetric Electron Telescope on the International Space Station.

Journal: Physical review letters

Published: February 05, 2025

Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma.

Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: January 21, 2025

Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer.

Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer.

Journal: Japanese journal of clinical oncology

Published: January 10, 2025

Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study.

Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: November 25, 2024

Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.

Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.

Journal: International journal of clinical oncology

Published: September 25, 2024

Showing 1-12 of 259

Last Updated: 09/26/2026